Illinois 104th General Assembly Status: Introduced 7 D cosponsors

HB5327      — PRESCRIPTION LABELING

Last action — Added Co-Sponsor Rep. Jaime M. Andrade, Jr.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced February 05, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.

Bill Text

We don't have the full text on file for this bill yet.

Read HB5327 on the official Illinois source →

Action History

  1. Added Co-Sponsor Rep. Jaime M. Andrade, Jr.

  2. Added Co-Sponsor Rep. Theresa Mah

  3. Added Co-Sponsor Rep. Justin Cochran

  4. Added Co-Sponsor Rep. Joyce Mason

  5. Added Co-Sponsor Rep. Will Guzzardi

  6. Added Co-Sponsor Rep. Daniel Didech

  7. Referred to Rules Committee

  8. First Reading

  9. Filed with the Clerk by Rep. Mary Beth Canty

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 6 co-sponsors · 176 not signed on

Sponsors (1)

Co-sponsors (6)

Not signed on (176)

176 members have not signed on to this bill.

Show all 176 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB5327      do?
Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Who sponsors HB5327     ?
HB5327      is sponsored by Mary Beth Canty (Democrat), Daniel Didech (Democrat), Will Guzzardi (Democrat), Joyce Mason (Democrat), Justin Cochran (Democrat), Theresa Mah (Democrat), and Jaime M. Andrade, Jr. (Democrat).
What is the current status of HB5327     ?
This bill has been introduced in the House. Introduced February 05, 2026. It must pass committee before a floor vote.
Where can I track HB5327     ?
Track HB5327      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB5327     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB5327     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →